Multiple unilateral schwannomas:: segmental neurofibromatosis type 2 or schwannomatosis?

被引:24
作者
Leverkus, M
Kluwe, L
Röll, EM
Becker, G
Bröcker, EB
Mautner, VF
Hamm, H
机构
[1] Univ Wurzburg, Dept Dermatol, D-97080 Wurzburg, Germany
[2] Univ Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany
[3] Univ Hosp Eppendorf, Dept Neurosurg, Erlangen, Germany
[4] Klinikum Nord Ochsenzoll, Dept Neurol, Hamburg, Germany
关键词
neurofibromatosis type 2; schwannomatosis; segmental neurofibromatosis; unilateral schwannomas;
D O I
10.1046/j.1365-2133.2003.05249.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Schwannomas are benign solitary tumours of the peripheral nerve sheaths. The occurrence of multiple schwannomas usually implies hereditary disease. The most frequent syndrome associated with multiple schwannomas is neurofibromatosis type 2 (NF2), which is defined by bilateral vestibular schwannomas. Schwannomatosis is a distinct disease characterized by multiple pathologically proven schwannomas in the absence of vestibular schwannomas. It is not currently known if the presence of multiple schwannomas confined to a limb may represent a mosaic form of NF2 or a distinct disease, because mutation analysis of these tumours is not routinely performed. We report a 31-year-old patient who presented with multiple slowly growing subcutaneous tumours on his left arm. His family history was negative for cutaneous tumours or central nervous system disease, and he did not have additional features of NF2. Magnetic resonance tomography and ophthalmological examination excluded vestibular schwannoma and eye stigmata of NF2. After resection of three tumours, histological analysis confirmed the diagnosis of benign schwannomas. Molecular genetic analysis by temperature gradient gel electrophoresis and microsatellite marker analysis demonstrated two distinct mutations of the NF2 gene (NF2 ) in two different schwannomas, with concomitant loss of heterozygosity in both tumours. In contrast, neither normal skin nor peripheral blood lymphocytes revealed mutations of NF2 . The clinical and molecular genetic findings suggest that the diagnosis in our patient is schwannomatosis rather than segmental NF2 because the mutations found in different tumours were not identical. The possibility of a localized predisposition for the acquisition of NF2 mutations is discussed.
引用
收藏
页码:804 / 809
页数:6
相关论文
共 39 条
[1]   High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH [J].
Bruder, CEG ;
Hirvelä, C ;
Tapia-Paez, I ;
Fransson, I ;
Segraves, R ;
Hamilton, G ;
Zhang, XX ;
Evans, DG ;
Wallace, AJ ;
Baser, ME ;
Zucman-Rossi, J ;
Hergersberg, M ;
Boltshauser, E ;
Papi, L ;
Rouleau, GA ;
Poptodorov, G ;
Jordanova, A ;
Rask-Andersen, H ;
Kluwe, L ;
Mautner, V ;
Sainio, M ;
Hung, G ;
Mathiesen, T ;
Möller, C ;
Pulst, SM ;
Harder, H ;
Heiberg, A ;
Honda, M ;
Miimura, M ;
Sahlén, S ;
Blennow, E ;
Albertson, DG ;
Pinkel, D ;
Dumanski, JP .
HUMAN MOLECULAR GENETICS, 2001, 10 (03) :271-282
[2]   A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene [J].
Bruder, CEG ;
Ichimura, K ;
Tingby, O ;
Hirakawa, K ;
Komatsuzaki, A ;
Tamura, A ;
Yuasa, Y ;
Collins, VP ;
Dumanski, JP .
HUMAN GENETICS, 1999, 104 (05) :418-424
[3]   A GENETIC-STUDY OF TYPE-2 NEUROFIBROMATOSIS IN THE UNITED-KINGDOM .2. GUIDELINES FOR GENETIC-COUNSELING [J].
EVANS, DGR ;
HUSON, SM ;
DONNAI, D ;
NEARY, W ;
BLAIR, V ;
NEWTON, V ;
STRACHAN, T ;
HARRIS, R .
JOURNAL OF MEDICAL GENETICS, 1992, 29 (12) :847-852
[4]   Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: A clinical and molecular study [J].
Evans, DGR ;
Mason, S ;
Huson, SM ;
Ponder, M ;
Harding, AE ;
Strachan, T .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (04) :361-366
[5]   Somatic mosaicism: A common cause of classic disease in tumor-prone syndromes? Lessons from type 2 neurofibromatosis [J].
Evans, DGR ;
Wallace, AJ ;
Wu, CL ;
Trueman, L ;
Ramsden, RT ;
Strachan, T .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (03) :727-736
[6]  
Gabriel Keith R., 1997, Current Opinion in Pediatrics, V9, P89, DOI 10.1097/00008480-199702000-00018
[7]  
Giovannini M, 2000, GENE DEV, V14, P1617
[8]   Molecular insights into neurofibromatosis 2 [J].
Gutmann, DH .
NEUROBIOLOGY OF DISEASE, 1997, 3 (04) :247-261
[9]   The neurofibromatoses: when less is more [J].
Gutmann, DH .
HUMAN MOLECULAR GENETICS, 2001, 10 (07) :747-755
[10]   The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2 [J].
Gutmann, DH ;
Aylsworth, A ;
Carey, JC ;
Korf, B ;
Marks, J ;
Pyeritz, RE ;
Rubenstein, A ;
Viskochil, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (01) :51-57